PACTT is pleased to announce that CHUV has entered into a license agreement with Biocompatibles, part of specialist healthcare group BTG International, focusing on the treatment of liver tumors, severe blood clots, varicose veins and advanced emphysema.

The agreement covers know-how and a patent protected, sustained release technology as well as sustained release drug product candidates that address unmet medical needs in embolization of a variety of hypervascularized tumors. In addition, CHUV and Biocompatibles are currently pursuing a development program under additional consulting and service agreements.

The goal of the collaboration is to develop a new class of anti-tumor devices aiming to induce severe ischemia coupled with a very high concentration of anti-angiogenic agents in the tumor periphery. “We hope for our patients that this new technique will improve the treatment of primary liver cancers” says Alban Denys, principal investigator and professor at the department of medical radiology at the CHUV. This innovative approach has recently been awarded by both, the Journal of Vascular and Interventional Radiology (JVIR outstanding laboratory research 2014) and by the European Society of Interventional Radiology (CIRSE award of excellence and innovation in interventional radiology 2015).

Two innovative projects from the 2015 spring call have been awarded the InnoTREK grant, a financial support that will allow the laureats to mature their ideas towards a start-up project.

Hosted by Professor Buclin, Division of Clinical Pharmacology at the CHUV, Séverine Petitprez will further develop the software EzeCHiel that will assist physicians in monitoring and adjusting the dosage of medicines to individual patients. Combining sophisticated pharmacokinetic algorithms with a personalized, automated and user-friendly approach the tool is poised to rapidly penetrate the market.

“Most central nervous system disorders are poorly detected before first symptoms appear because of a lack of medical tests to diagnose them appropriately. The need for such tests is therefore great. Early diagnosis could significantly enhance chances for successful treatment, and help in the development of personalized medicine” says Robert Lütjens, founder of the BioLemantis project. During his grant period in the laboratory of Professor Ron Stoop, Centre for Psychiatric Neurosciences, he sets out to establish proof of concept for a new biosensor technology to diagnose autism spectrum disorders.

The InnoTREK grant, organised by the PACTT with the support from the FIT as part of the InnoPACTT fund, sponsors selected researchers at UNIL and CHUV who have the ambition to venture into the business world with their innovative projects. The successful projects are chosen in a competitive process from applications received during the two calls per year. Since the launch in 2014, 9 laureates of UNIL-CHUV have benefited from the InnoTREK grant.

BioInnovation Day returns for its 7th edition on 23 June 2015 at the CHUV in Lausanne. This bi-annual meeting showcases Western Switzerland’s most innovative projects in life sciences coming from academia and early-stage start-ups. This year, 35 entrepreneurs and researchers will present their companies or projects in areas including human therapeutics, medical devices, research tools, digital health and diagnostics. Each presenter will have 5 minutes to pitch their project as well as the opportunity for one-on-one discussions with potential partners, investors and service providers during networking sessions throughout the day.

VIEW THE PROGRAMME HERE

The meeting will open with a lively panel discussion among venture capital and strategic investors from Neomed, Index Ventures, Omega Funds and Debiopharm Diagnostics.

This event’s programme also offers great opportunities to learn from successful entrepreneurs how to manage a life science start-up and the challenges and solutions to expect along the way. Keynote speakers include Philippe Dro, CEO of GlycoVaxyn and Vincent Charlon, CEO of Anergis.

REGISTER HERE

Details of the event:
Tuesday, 23 June 2015
08:30 – 18:00
Registration opens at 08:30
CHUV, Auditorium César Roux, Rue du Bugnon 46, 1011 Lausanne
Registration fee CHF 100.-
Website: www.bioinnovation.ch
Registration extended until June 16th: Register here
Programme: Click here

Participants, Presenters, and Exhibitors
Please register here

Details of BioInnovation Day 2015:
Tuesday, 23 June 2015
CHUV, Auditorium César Roux, Rue du Bugnon 46, 1011 Lausanne
09:00 – 17:00
Registration opens at 08:00

Building upon the success of the six previous editions hosted in Geneva and Lausanne, BioInnovation Day 2015 is an opportunity for researchers, scientist-entrepreneurs and early stage start-up ventures to pitch their projects to an audience of peers, venture capitalists, investors and licensing / partnering professionals from industry.

The 2015 edition of the BioInnovation Day will feature a panel discussion with venture capitalists discussing the European venture capital landscape and how to attract venture capital funding. The meeting will also highlight the perspective of the entrepreneur with invited speakers including a new start-up business tracing its origins back to a previous BioInnovation Day pitch and a successful serial entrepreneur. They will present their experiences in transforming innovative research ideas into viable and functional companies.

BioInnovation Day 2015 continues the partnership with the Fondation Eclosion, who has again generously offered the BioInnovation-Eclosion Prize, a cash prize of CHF 10,000 for the most innovative project.

The programme for BioInnovation Day 2015 will consist of three sessions of project pitches featuring projects selected from both academic research and from start-up companies.

BioInnovation Day welcomes registration for projects from academic researchers, scientist-entrepreneurs and start-up companies from Western Switzerland. Projects must be submitted by 18 May 2015 and will be selected by the BioInnovation Day committee. Those selected will be asked to present his or her project in a 5 minute “elevator pitch”.

More information and registration on the website of the event.

JOURNÉE DE L’INNOVATION ET DES PME 2015 – HEALTH VALLEY : MODE D’EMPLOI

Après une première édition à Microcity (EPFL/Neuchâtel) en 2014, la Journée de l’Innovation et des PME revient le 12 mai 2015 au SwissTech Convention Center de l’EPFL. Organisée conjointement par Le Réseau, le Centre Patronal et l’EPFL, l’événement réunit les acteurs de l’innovation, des PME et du monde politique.

Thème 2015 : health valley et innovation dans la santé

Objectifs : sensibiliser les élus et l’administration aux besoins des entreprises et encourager le développement de conditions-cadre favorables à l’innovation.

Au programme :

Des conférences et ateliers
Un salon de start-up
Un espace de réseautage
Des bureaux pour réseauter en privé

Le programme est disponible ICI.

Informations et enregistrement sur le site du réseau

BioInnovation Day is back in Lausanne and will take place on June 23rd at CHUV

The objectives of the Bioinnovation Day are:

• to provide an opportunity for researchers, scientist-entrepreneurs and early stage start-up companies to present new developments with commercial potential in the field of life sciences.
• to stimulate innovation by encouraging interactions between scientists, start-ups, investors and industry.
• to present and discuss business opportunities.
• to share experience in life-science start-ups.

Visit the bioinnovation website for more details !

More information

SPRING CALL 2015     You are a UNIL-CHUV scientist and have a spin-off idea but no financial support to start it

Apply for a one-year InnoTREK grant to launch your spin-off!

PACTT, Technology Transfer Office of UNIL-CHUV, is calling for spin-off projects for the InnoTREK grant part of InnoPACTT, a financial fund to accelerate innovation and spin-off creation. With this InnoTREK support, PACTT wants to encourage researchers with innovative ideas to jump into the entrepreneurship adventure.

Deadline for application: March 23, 2015

Documents available on:

https://www.pactt.ch/innotrek/

For more information please contact us on:

innopactt.info@chuv.ch

Phones:          021.314.39.84

                        021.314.49.58

                        021 314.82.19

We are moving on Tuesday, March 10!

During this transition we may be temporarily unavailable and thank you in advance for your understanding.

As of Wednesday 11th you can find us on the 5th floor at Bugnon 21 (same building as before), offices 5004 to 5007.

The European Framework Programme Horizon 2020 launched last year allocates a substantial part of the total funding to bringing research to the market. Support for SME participation in the programme was stepped up in comparison to the 7th Framework Programme and industrial entities should take advantage of this ‘innovation’ aspect.
Almost all collaborative calls are open to Swiss entities active in RDI. Swiss industry participation is possible and encouraged. Do not hesitate to contact Euresearch in order to find out about the available funding possibilities.

More information